Zynex Chief Operating Officer Anna Lucsok joined Steve Darling from Proactive to discuss the company’s commitment to providing non-opioid pain management solutions and its robust reimbursement strategy. Since joining Zynex in January 2021, Lucsok has overseen key functions, including sales, reimbursement, quality, IT, HR, compliance, and legal operations. Lucsok emphasized Zynex’s ability to work with all insurance providers, successfully navigating a complex network of thousands of carriers to ensure patients receive coverage for its medical devices. “Our reimbursement team has been very successful at identifying how to secure coverage for our patients,” she noted. Zynex’s product portfolio includes electrotherapy, bracing, cervical traction, and hot and cold therapy, positioning the company as a leader in alternative pain management. Lucsok highlighted the company's goal of becoming a household name for non-opioid pain relief, offering solutions that reduce reliance on medication. On the sales front, Zynex has seen sales rep productivity double over the past two years, a testament to the company’s strategic expansion and operational efficiency. Despite the challenges associated with third-party payers, Lucsok credited the company’s strong team and technology for driving success. Looking ahead, Zynex plans to expand its sales force and develop new products, reinforcing its vision of becoming a one-stop shop for non-medication pain management solutions. #proactiveinvestors #zynexinc #nasdaq #zyxi #healthcare #q2 #finanacials #PainManagement #NonOpioidSolutions #HealthcareInnovation #MedicalDevices #InsuranceReimbursement #AnnaLucsok #Electrotherapy #ChronicPainRelief #ProactiveInterviews